In agreement with these results, pre-clinical studies using transgenic MMTVPyVmT (mouse mammary tumor virus-polyoma middle tumor-antigen) models of cancer, have displayed a pro-angiogenic contribution of ADPN to enhanced mammary tumor growth in vivo [63]. The gene discussed is ADIPOQ; the disease is breast cancer.